Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Tekpli

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Nature Communications|November 11, 2017
DNA methylation at enhancers identifies distinct breast cancer lineagesThomas Fleischer, Xavier Tekpli, Anthony Mathelier, et al.
Frontiers in Oncology|May 2, 2022
Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer TissueMarta Tellez-Gabriel, Xavier Tekpli, Trine M Reine, et al.
International Journal of Cancer|August 25, 2019
Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancersMarianne E Nome, Leslie R Euceda, Shakila Jabeen, et al.
Chemico-Biological Interactions|November 20, 2013
Protective action of n-3 fatty acids on benzo[a]pyrene-induced apoptosis through the plasma membrane remodeling-dependent NHE1 pathwayBéatrice Dendelé, Xavier Tekpli, Kévin Hardonnière, et al.
Nature Communications|December 5, 2019
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironmentXavier Tekpli, Tonje Lien, Andreas Hagen Røssevold, et al.
Future Oncology (London, England)|July 29, 2024
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancerKamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Nature Communications|November 11, 2017
DNA methylation at enhancers identifies distinct breast cancer lineagesThomas Fleischer, Xavier Tekpli, Anthony Mathelier, et al.
Frontiers in Oncology|May 2, 2022
Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer TissueMarta Tellez-Gabriel, Xavier Tekpli, Trine M Reine, et al.
International Journal of Cancer|August 25, 2019
Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancersMarianne E Nome, Leslie R Euceda, Shakila Jabeen, et al.
Chemico-Biological Interactions|November 20, 2013
Protective action of n-3 fatty acids on benzo[a]pyrene-induced apoptosis through the plasma membrane remodeling-dependent NHE1 pathwayBéatrice Dendelé, Xavier Tekpli, Kévin Hardonnière, et al.
Nature Communications|December 5, 2019
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironmentXavier Tekpli, Tonje Lien, Andreas Hagen Røssevold, et al.
Future Oncology (London, England)|July 29, 2024
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancerKamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler, et al.
Pageof 6